3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
2
Status
Withdrawn
2
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Other solid neoplasm
2
Lymphoid
1
Conditions
Solid Tumor
2
Interventions
Cisplatin
7
Pemetrexed
6
atezolizumab
5
Carboplatin
4
tislelizumab
3
Paclitaxel
3
Leucovorin
3
Filgrastim
3
Etoposide
3
vistusertib
2
pembrolizumab
2
Vincristine
2
Topotecan
2
Temozolomide
2
Tegafur
2
Sorafenib
2
Irinotecan
2
Immunoenzyme Techniques
2
Gemcitabine
2
Docetaxel
2
Cyclophosphamide
2
zirconium-89-trastuzumab
1
vandetanib
1
toripalimab
1
temsirolimus
1
tanespimycin
1
talazoparib
1
soblidotin
1
selinexor
1
sargramostim
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Withdrawn
×
vistusertib
×
Other solid neoplasm
×
Clear all
NCT03166176
2019-05-20
TSC1/2_SC
Samsung Medical Center
Phase 2
Withdrawn
NCT03166904
2019-05-20
RICTOR_SC
Samsung Medical Center
Phase 2
Withdrawn